Helicobacter hepaticus and Liver Disease in Mice
Author Information
Author(s): Jerry M. Rice
Primary Institution: National Cancer Institute, Frederick, Maryland, USA
Hypothesis
How does Helicobacter hepaticus contribute to liver disease and cancer in certain strains of mice?
Conclusion
Helicobacter hepaticus is associated with chronic hepatitis and liver tumors in laboratory mice.
Supporting Evidence
- Hepatitis prevalence increased to nearly 100% in male A/JCr mice by 1 year of age.
- Hepatocellular tumors were often present in mice with hepatitis.
- Helicobacter hepaticus was identified as a new species related to H. pylori.
- Antibiotic treatments were evaluated for their effectiveness in eradicating H. hepaticus.
Takeaway
Some mice can get really sick and develop tumors because of a tiny germ called Helicobacter hepaticus that lives in their liver.
Methodology
The study involved observing liver disease in specific mouse strains and identifying the presence of Helicobacter hepaticus through various microbiological techniques.
Limitations
The study primarily focused on specific mouse strains, which may not represent all rodents or the potential effects in humans.
Participant Demographics
The study involved male and female mice of various strains, with male mice being more severely affected.
Want to read the original?
Access the complete publication on the publisher's website